Haleon plc filings document foreign private issuer disclosures for a global consumer health company whose American depositary shares trade under HLN. Form 6-K reports cover current information such as trading statements, ordinary-share repurchases for cancellation, total voting rights and capital, and annual general meeting poll results.
The filing record also includes debt-market disclosures, including listing particulars for the Euro Medium Term Note programme of Haleon UK Capital plc and Haleon Netherlands Capital B.V. guaranteed by Haleon. Governance and capital-structure disclosures address directors' remuneration, board elections, dividend approvals, special resolutions, ordinary shares, treasury shares, voting rights and shareholder notification thresholds.
Haleon plc disclosed director/PDMR share transactions showing that two senior officers participated in the company's Share Reward Plan. Adrian Morris (General Counsel) and Tamara Rogers (Chief Marketing Officer) each acquired 36 Partnership Shares at £3.563199 per share and were awarded 36 Matching Shares at nil cost, for an aggregated 72 shares each. The transactions occurred on 11 August 2025 on the London Stock Exchange and were announced by the company, reflecting routine compensation-related share acquisitions under its Share Reward Plan.
Haleon plc purchased 1,200,000 ordinary shares of £0.01 each for cancellation under the second tranche of its share buyback programme announced 31 July 2025. Purchases took place on 11 August 2025 on the London Stock Exchange with a highest price of 357.0000p, lowest price of 352.2000p and a volume-weighted average price of 354.2107p. After settlement, registered share capital is 8,978,535,788 ordinary shares, with 3,880,205 held as treasury, leaving 8,974,655,583 ordinary shares with voting rights. A full trade breakdown is published via the provided RNS link and on the company's investor website; the announcement states it does not constitute an offer.
Haleon plc purchased 856,760 ordinary shares of £0.01 each for cancellation under the second tranche of its share buyback programme announced 31 July 2025. The purchases were executed on 08 August 2025 on the London Stock Exchange at prices between 353.5000p and 356.1000p, with a volume-weighted average price of 354.6173p.
Following settlement the company's registered share capital is 8,979,735,788 ordinary shares, of which 3,880,205 are held as treasury shares, leaving 8,975,855,583 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided RNS link and on Haleon's investor website.
Haleon plc (LSE/NYSE: HLN) filed a Form 6-K to report activity under the second tranche of its share-buyback programme announced on 31 July 2025. On 7 August 2025 the company purchased 1,330,960 ordinary shares (nominal £0.01) for cancellation on the London Stock Exchange at prices between 346.5p – 354.4p, delivering a volume-weighted average price of 351.6198p.
Post-settlement, Haleon’s registered share capital stands at 8,980,592,548 ordinary shares, of which 3,880,205 are held in treasury, leaving 8,976,712,343 voting shares outstanding. A detailed trade log is available via the RNS link and on the company’s investor website. No other material financial information or guidance is provided in this filing.
Haleon plc’s 7 Aug 2025 Form 6-K encloses a UK TR-1 notice showing Wellington Management Group LLP has fallen below the 5 % disclosure threshold.
- Date threshold crossed: 6 Aug 2025
- Current holding: 4.96 % of voting rights (445,697,628 votes)
- Prior holding: 5.29 %
- Break-down: 4.66 % ordinary shares (418.6 m votes), 0.29 % depositary receipts (26.4 m votes), 0.01 % cash-settled equity swaps (0.64 m votes)
- Change: roughly 0.33 ppt (≈28 m votes) disposed
The disclosure is mandatory under FCA DTR 5 and does not include earnings or operational updates. Investors may view the reduced stake as a marginal decline in long-only institutional ownership; however, no immediate strategic implications were provided.
Haleon plc has filed a Form 6-K outlining the latest activity under the second tranche of its share-buyback programme announced on 31 July 2025.
On 6 Aug 2025 the company repurchased 1,517,728 ordinary shares on the London Stock Exchange at a volume-weighted average price of 347.5568 p (high 350.3000 p, low 346.3000 p). No shares were bought on Cboe BXE or CXE. All acquired shares will be cancelled.
Post-transaction, Haleon’s issued share capital totals 8,981,923,508 shares of £0.01 each, with 3,880,205 held in treasury, leaving 8,978,043,303 voting shares outstanding. The purchase equates to roughly 0.017 % of shares in issue and does not materially alter the company’s capital structure.
No earnings figures, guidance, or other material financial disclosures accompany this filing. The update is chiefly administrative, confirming incremental progress toward the ongoing buyback plan.
On 05 Aug 2025, Haleon plc (HLN) filed a Form 6-K confirming execution of the second tranche of its share-buyback programme announced 31 Jul 2025. On 04 Aug 2025 the company repurchased 1,418,324 ordinary shares on the London Stock Exchange for cancellation. Purchase prices ranged from 355.90p to 364.60p, with a volume-weighted average of 358.534p. After settlement, issued share capital stands at 8,984,952,236 shares of £0.01 each; 3,880,205 shares are held in treasury, leaving 8,981,072,031 shares entitled to vote. A detailed trade log is available via the LSE RNS link and on Haleon’s investor site. No additional financial results or forward guidance were provided.
Haleon plc (HLN) Form 6-K: The company reports the purchase and cancellation of 1,281,000 ordinary shares (£0.01 par) on 1 Aug 2025, executed on the London Stock Exchange as part of the second tranche of its share-buyback programme announced 31 Jul 2025.
- Pricing: highest 368.4000p, lowest 359.0000p, volume-weighted average 364.8941p.
- The repurchase equals roughly 0.014% of the 8.98 bn shares outstanding.
- Post-settlement share capital totals 8,986,370,560, of which 3,880,205 are treasury shares, leaving 8,982,490,355 shares with voting rights.
The updated voting share count should be used for FCA disclosure thresholds. A trade-by-trade breakdown is available via the linked RNS PDF and on Haleon’s investor website. No additional financial or operational disclosures accompany this filing.